HFE polymorphism in German patients with hereditary haemochromatosis;Nachweis des HFE-polymorphismus bei deutschen patienten mit hereditarer hamochromatose

Deutsche Medizinische Wochenschrift

Volumn 124, Issue 48, 1999, Pages 1448-1452

  Erhardt, A ^a   Niederau, C ^b   Osman, Y ^a   Hassan, M ^a   Haussinger D ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b St Josef Hospital Oberhausen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; CHROMOSOME 6; GENE LOCATION; GENE MUTATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GEOGRAPHIC DISTRIBUTION; GERMANY; HEMOCHROMATOSIS; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS;

EID: 0033521013     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1035680     Document Type: Article

References (30)

1. Barton, J. C., R. Sawada-Hirai, B. E. Rothenberg, R. T. Acton: Two novel missense mutations of the HFE gene (1105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands. Blood Cells Mol. Dis. 25 (1999), 147-155.
2. Beutler, E.: Genetic irony beyond haemochromatosis: clinical effects of HLA-H mutations. Lancet 349 (1997), 296-297.
3. Beutler, E.: The significance of the 187G (H63D) mutation in hemochromatosis. Am. J. Hum. Genet. 61 (1997), 762-764.
4. Beutler, E., T. Gelbart: HLA-H mutations in the Ashkenazi Jewish population. Blood Cells Mol. Dis. 23 (1997), 95-98.
5. Chang, J. G., T. C. Liu, S. F. Lin: Rapid diagnosis of the HLA-H gene Cys 282 Tyr mutation in hemochromatosis by polymerase chain reaction - a very rare mutation in the Chinese population. Blood 89 (1997), 3492-3493.
6. Datz, C., M. R. Lalloz, W. Vogel, I. Graziadei, F. Hackl, G. Vautier, D. M. Layton, T. Maier-Dobersberger, P. Ferenci, E. Penner, F. Sandhofer, A. Bomford, B. Paulweber: Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis. J. Hepatol. 27 (1997), 773-779.
7. de Sousa, M., R. Reimao, R. Lacerda, P. Hugo, S. H. Kaufmann, G. Porto: Iron overload in beta 2-microglobulin-deficient mice. Immunol. Lett. 39 (1994), 105-111.
8. Feder, J. N., A. Gnirke, W. Thomas, Z. Tsuchihashi, D. A. Ruddy, A. Basava, F. Dormishian, R. Jr Domingo, M. C. Ellis, A. Fullan, L. M. Hinton, N. L. Jones, B. E. Kimmel, G. S. Kronmal, P. Lauer, V. K. Lee, D. B. Loeb, F. A. Mapa, E. McClelland, N. C. Meyer, G. A. Mintier, N. Moeller, T. Moore, E. Morikang, R. K. Wolff: A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13 (1996), 399-408.
9. Feder, J. N., D. M. Penny, A. Irrinki, V. K. Lee, J. A. Lebron, N. Watson, Z. Tsuchihashi, E. Sigal, P. J Bjorkman, R. C. Schatzman: The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc. Natl. Acad. Sci. U.S.A. 95 (1998), 1472-1477.
10. Feder, J. N., Z. Tsuchihashi, A. Irrinki, V. K. Lee, F. A. Mapa, E. Morikang, C. E. Prass, S. M. Starnes, R. K. Wolff, S. Parkkila, W. S. Sly, R. C Schatzman: The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J. Biol. Chem. 272 (1997), 14025-14028.
11. Gottschalk, R., C. Seidl, T. Loffler, E. Seifried, D. Hoelzer, J. P. Kaltwasser: HFE codon 63/282 (H63D/C282Y) dimorphism in German patients with genetic hemochromatosis. Tissue Antigens. 51 (1998), 270-275.
12. Jazwinska, E. C., L. M. Cullen, F. Busfield, W. R. Pyper, S. I. Webb, L. W. Powell, C. P. Morris, T. P. Walsh: Haemochromatosis and HLA-H. Nat. Genet. 14 (1996), 249-251.
13. Jouanolle, A. M., G. Gandon, P. Jezequel, M. Blayau, M. L. Campion, J. Yaouanq, J. Mosser, P. Fergelot, B. Chauvel, P. Bouric, G. Carn, N. Andrieux, I. Gicquel, J. Y. Le Gall, V. David: Haemochromatosis and HLA-H. Nat.Genet. 14 (1996), 251-252.
14. Lebron, J. A., M. J. Bennett, D. E. Vaughn, A. J. Chirino, P. M. Snow, G. A. Mintier, J. N. Feder, P. J. Bjorkman: Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 93 (1998), 111-123.
15. Merryweather-Clarke, A. T., J. J. Pointon, J. D. Shearman, K. J. Robson: Global prevalence of putative haemochromatosis mutations. J. Med. Genet. 34 (1997), 275-278.
16. Merryweather, Clarke AT, M. Worwood, L. Parkinson, C. Mattock, J. J. Pointon, J. D. Shearman, K. J. Robson: The effect of HFE mutations on serum ferritin and transferrin saturation in the Jersey population. Br. J. Haematol. 101 (1998), 369-373.
17. Mura, C., O. Raguenes, C. Ferec: HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 93 (1999), 2502-2505.
18. Niederau, C., R. Fischer, A. Purschel, W. Stremmel, D. Häussinger, G. Strohmeyer: Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 110 (1996), 1107-1119.
19. Niederau, C., R. Fischer, A. Sonnenberg, W. Stremmel, H. J. Trampisch, G. Strohmeyer: Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N. Engl. J. Med. 313 (1985), 1256-1262.
20. Niederau, C., M. Niederau, S. Lange, A. Littauer, N. Abdel-Jalil, M. Maurer, D. Häussinger, G. Strohmeyer: Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany. Ann. Intern. Med. 128 (1998), 337-345.
21. Parkkila, S., A. Waheed, R. S. Britton, B. R. Bacon, X. Y. Zhou, S. Tomatsu, R. E. Fleming, W. S. Sly: Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc. Natl. Acad. Sci. U.S.A. 94 (1997), 13198-13202.
22. Piperno, A., M. Sampietro, A. Pietrangelo, C. Arosio, L. Lupica, G. Montosi, A. Vergani, M. Fraquelli, D. Girelli, P. Pasquero, A. Roetto, P. Gasparini, S. Fargion, D. Conte, C. Camaschella: Heterogeneity of hemochromatosis in Italy. Gastroenterology 114 (1998), 996-1002.
23. Piperno, A., A. Vergani, I. Malosio, L. Parma, L. Fossati, A. Ricci, G. Bovo, G. Boari, G. Mancia: Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations. Hepatology 28 (1998), 1105-1109.
24. Roberts, A. G., S. D. Whatley, R. R. Morgan, M. Worwood, G. H. Elder: Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 349 (1997), 321-323.
25. Roth, M., P. Giraldo, G. Hariti, E. S. Poloni, A. Sanchez-Mazas, G. F. D. Stefano, J. M. Dugoujon, H.Coppin: Absence of the hemochromatosis gene Cys282Tyr mutation in three ethnic groups from Algeria (Mzab), Ethiopia, and Senegal. Immunogenetics 46 (1997), 222-225.
26. Sampietro, M., A. Piperno, L. Lupica, C. Arosio, A. Vergani, N. Corbetta, I. Malosio, M. Mattioli, A. L. Fracanzani, M. D. Cappellini, G. Fiorelli, S. Fargion: High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology 27 (1998), 181-184.
27. Waheed, A., S. Parkkila, X. Y. Zhou, S. Tomatsu, Z. Tsuchihashi, J. N. Feder, R. C. Schatzman, R. S. Britton, B. R. Bacon, W. S. Sly: Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc. Natl. Acad. Sci. U.S.A. 94 (1997), 12384-12389.
28. Wallace, D. F., J. S. Dooley, A. P. Walker: A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote. Gastroenterology 116 (1999), 1409-1412.
29. Willis, G., B. A. Jennings, E. Goodman, I. W. Fellows, J. Z. Wimperis: A high prevalence of HLA-H 845A mutations in hemochromatosis patients and the normal population in eastern England. Blood Cells Mol. Dis. 23 (1997), 288-291.
30. Zhou, X. Y., S. Tomatsu, R. E. Fleming, S. Parkkila, A. Waheed, J. Jiang, Y. Fei, E. M. Brunt, D. A. Ruddy, C. E. Prass, R. C. Schatzman, R. O'Neill, R. S. Britton, B. R. Bacon, W. S. Sly: HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc. Natl. Acad. Sci. U.S.A. 95 (1998), 2492-2497.